NeoChord DS1000 System
Degenerative Mitral Valve Regurgitation
NAActive
Key Facts
About NeoChord
NeoChord is a pioneering medical device company developing and commercializing a novel, minimally invasive solution for mitral valve repair. Its core technology, the DS1000 system, allows for transapical implantation of artificial chordae on a beating heart under echocardiographic guidance, offering a potential alternative to traditional open surgery or complex transcatheter approaches. The company is CE-marked and commercially active in Europe but remains in the investigational stage in the United States. With a seasoned board and a focus on a large cardiovascular market, NeoChord is positioned as a specialist in direct repair techniques.
View full company profile